GBT Technologies Inc. ( OTCMKTS: GTCH ) announced on October 27th 2020 that GBT Tokenize Corp (“GBT/Tokenize”), the Company’s joint venture, has settled qTerm device’s structures, adding two features.
qTerm is a human vitals device which is powered by Artificial Intelligence technology. It aims to measure human vitals easily with only the touch of a finger. The device also received its Trademark allowance notice. It will be presented on the merchandise and packaging which is mandatory by the United State Patent Office (“USPTO”).
In its initial publication, the GBT Technologies Inc. ( OTCMKTS: GTCH ) qTerm device is designed to measure body temperature, blood oxygen level and heart rate. All with an easy touch of the finger. Progressive circuitry and sensory systems will be applied in order to allow these features. These three vitals measurements can offer significant health factors for premature viral infection detection. The device can be effortlessly attached to the back of a smartphone or used as a separate gadget. The user will receive a timely visual alert in addition to the reading. qTerm smart phone app will keep a history for the user’s accounts and provide numerical and statistical data about the operator’s body temperature.
qTerm’s mobile app is intended to be powered by Artificial Intelligence, anonymously and securely gathering the user data, constructing theoretically a worldwide ‘thermal map’ to alert about possible health risks proximities. The device’s original features have been determined and GBT/Tokenize is looking to produce its original models.
GBT/Tokenize filed an all-inclusive non-provisional patent with USPTO for the qTerm project. The patent contains a wide assortment of features to be applied within the device according to the Company’s arranged releases and milestones. The application has been allocated the serial number 16983289 and the filing date is for August 3, 2020.
GBT Technologies Inc. ( OTCMKTS: GTCH ) Security Details
GBT Technologies Inc. ( OTCMKTS: GTCH ) closed at $0.011 at the end of the trading day on October 27th 2020. The company has been trading in a range of $0.0087 as the 52-week low and $2.04 as the 52-week high. There are 212,398,142 shares outstanding, 110,644,088 shares restricted, 101,754,054 shares restricted, and 5,266,985 shares in the float. The share structure was last updated on September 30th 2020. The 30-day average volume is 1,537,566.